Cannabis against chronic musculoskeletal pain: a scoping review on users and their perceptions
Abstract Background: Chronic musculoskeletal pain (CMP) may lead to reduced physical function and is the most common cause of chronic…
adverse effects
Sex differences in medical cannabis-related adverse effects
Abstract Supplemental Digital Content is Available in the Text. Women are more susceptible to medical cannabis–related adverse effects because of…
Targeting the endocannabinoid system for management of HIV-associated neuropathic pain: A systematic review
Abstract Human immunodeficiency virus (HIV) infection and antiretroviral therapy can independently induce HIV-associated neuropathic pain (HIV-NP). There is a dearth…
Cannabis, More Than the Euphoria: Its Therapeutic Use in Drug-Resistant Epilepsy
Abstract A significant number of epilepsy patients are refractory to conventional antiepileptic drugs. These patients experience considerable neurocognitive impairments that…
Integrated safety profile of selinexor in multiple myeloma: experience from 437 patients enrolled in clinical trials
Abstract Selinexor is an oral, small molecule inhibitor of the nuclear export protein exportin 1 with demonstrated activity in hematologic…
Medical Cannabis for the Primary Care Physician
Abstract Medical cannabis use is common in the United States and increasingly more socially acceptable. As more patients seek out…
Cannabidiol Adverse Effects and Toxicity
Abstract Background: Currently, there is a great interest in the potential medical use of cannabidiol (CBD), a non-intoxicating cannabinoid. Productive…